Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Nicolau

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Pneumoftiziologia : Revista Societatii Romane De Pneumoftiziologie|January 1, 1994
[Speleoplasty, a possible alternative in the surgical treatment of cavitary pulmonary tuberculosis]D Nicolau
Connecticut Medicine|October 1, 1992
Once-daily aminoglycosidesD Nicolau, R Quintiliani, C H Nightingale
Connecticut Medicine|May 1, 1992
Ofloxacin vs ciprofloxacin: a comparisonD Nicolau, R Quintiliani, C H Nightingale
Ftiziologia|November 1, 1971
[Association of collagenosis with Brill-Symmers syndrome (presentation of a case)]D Burnea, A Brăileanu, P Galgenu, et al.
Pediatria|March 1, 1973
[Immunological control of anti-pertussis vaccination]M W Zalman, D N Gherman, D Nicolau
Connecticut Medicine|October 1, 1998
Trovafloxacin: fourth generation fluoroquinoloneJ McNabb, D Nicolau, R Quintiliani, et al.
Medical Hypotheses|June 7, 2020
What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?Lucas A D Nicolau, Pedro J C Magalhães, Mariana L Vale
Biosensors & Bioelectronics|December 14, 2004
A novel biosensor for mercuric ions based on motor proteinsR Martinez-Neira, M Kekic, D Nicolau, et al.
Journal of Nanoscience and Nanotechnology|August 3, 2005
Hierarchy of DNA immobilization and hybridization on poly-L-lysine using an atomic force microscopy studyP D Sawant, G S Watson, D Nicolau, et al.
Expert Review of Clinical Pharmacology|July 21, 2020
Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insightLucas A D Nicolau, Isabela R S G Nolêto, Jand V R Medeiros
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Pneumoftiziologia : Revista Societatii Romane De Pneumoftiziologie|January 1, 1994
[Speleoplasty, a possible alternative in the surgical treatment of cavitary pulmonary tuberculosis]D Nicolau
Connecticut Medicine|October 1, 1992
Once-daily aminoglycosidesD Nicolau, R Quintiliani, C H Nightingale
Connecticut Medicine|May 1, 1992
Ofloxacin vs ciprofloxacin: a comparisonD Nicolau, R Quintiliani, C H Nightingale
Ftiziologia|November 1, 1971
[Association of collagenosis with Brill-Symmers syndrome (presentation of a case)]D Burnea, A Brăileanu, P Galgenu, et al.
Pediatria|March 1, 1973
[Immunological control of anti-pertussis vaccination]M W Zalman, D N Gherman, D Nicolau
Connecticut Medicine|October 1, 1998
Trovafloxacin: fourth generation fluoroquinoloneJ McNabb, D Nicolau, R Quintiliani, et al.
Medical Hypotheses|June 7, 2020
What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?Lucas A D Nicolau, Pedro J C Magalhães, Mariana L Vale
Biosensors & Bioelectronics|December 14, 2004
A novel biosensor for mercuric ions based on motor proteinsR Martinez-Neira, M Kekic, D Nicolau, et al.
Journal of Nanoscience and Nanotechnology|August 3, 2005
Hierarchy of DNA immobilization and hybridization on poly-L-lysine using an atomic force microscopy studyP D Sawant, G S Watson, D Nicolau, et al.
Expert Review of Clinical Pharmacology|July 21, 2020
Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insightLucas A D Nicolau, Isabela R S G Nolêto, Jand V R Medeiros
Pageof 5